Statins Beat Every Supplement Tested for LDL Reduction — But the Study Has Flaws
A Cleveland Clinic trial pitted rosuvastatin against six supplements. The drug won — but the supplement choices raise serious questions.
Summary
The SPORT trial from the Cleveland Clinic compared rosuvastatin (Crestor) against fish oil, cinnamon, garlic, turmeric, plant sterols, and red yeast rice for LDL cholesterol reduction over one month. The statin lowered LDL by 35% on average — and reduced LDL in every single participant. No supplement beat the placebo, and garlic appeared to raise LDL slightly. However, NutritionFacts.org's Dr. Michael Greger scrutinizes the trial's design: the red yeast rice brand had zero active ingredients, the garlic product was odor-free and adulterated, and the study was funded by Crestor's manufacturer. Stronger cholesterol-lowering options like berberine, bergamot, psyllium, and artichoke were excluded entirely. The key takeaway is that whole foods outperform poorly regulated supplements, and statins remain highly effective — but this study's supplement selection was arguably rigged.
Detailed Summary
The SPORT trial, conducted at the Cleveland Clinic and published to considerable attention, randomized participants to receive either a starting dose of rosuvastatin (Crestor), a placebo, or one of six dietary supplements: fish oil, cinnamon, garlic, turmeric, plant sterols, or red yeast rice. The primary outcome was change in LDL cholesterol after approximately one month. The results were stark — rosuvastatin reduced LDL by an average of 35%, and critically, every single participant on the drug saw their LDL go down, with reductions ranging from 18% to over 50%. By contrast, the supplements performed no better than placebo, with individual responses resembling a coin flip between LDL rising or falling.
While the headline result — statins outperform supplements — is not surprising, Greger dissects serious methodological concerns. The trial was funded by AstraZeneca, the maker of Crestor, which still earns over a billion dollars annually despite the drug being off-patent. The supplement selection raises red flags: fish oil and cinnamon are not marketed as cholesterol-lowering agents, and turmeric requires at least eight weeks to show modest effects (under 10 mg/dL reduction) — far longer than the trial's one-month window. The red yeast rice brand chosen was independently found to contain zero active monacolins, the compounds responsible for its LDL-lowering effects, making its inclusion arguably a straw-man comparison. The garlic product used was odor-free and contained 15 other ingredients, stripping out the active sulfur compounds shown to lower LDL at doses as low as one-eighth of a teaspoon of garlic powder daily.
Notably absent from the trial were supplements with stronger evidence bases: berberine, bergamot, psyllium, and artichoke extract — all of which have meaningful LDL-lowering data. The plant sterol product used also contained questionable ingredients and may not have been given sufficient time to act, though phytosterols typically show effects within two weeks.
A broader and actionable lesson emerges: dietary supplements are poorly regulated in the U.S., and label claims often do not match actual content. Greger advocates for whole foods over extracts wherever possible — real garlic powder instead of garlic supplements, barberries instead of berberine capsules, artichoke hearts instead of artichoke extract. These deliver the active compounds in their natural matrix without the regulatory gray zone.
For longevity-focused individuals, the video reinforces that statins, at starter doses, are highly effective and have decades of safety data behind them — and should not be dismissed based on supplement misinformation. At the same time, the evidence-backed dietary approach (including the Portfolio Diet, plant sterols from whole foods, and other food-based interventions covered in Greger's broader series) remains a powerful adjunct or alternative for those unwilling or unable to take statins. The critical takeaway is to evaluate supplement studies with a sharp eye toward funding sources, product quality, and whether the most evidence-supported comparators were even included.
Key Findings
- Rosuvastatin lowered LDL by 35% on average and reduced LDL in 100% of participants — no supplement came close.
- The red yeast rice brand used in the trial contained zero active ingredients, invalidating it as a fair comparator.
- The garlic supplement was odor-free and adulterated; real garlic powder shows LDL-lowering effects at tiny doses.
- Turmeric requires 8+ weeks to show modest LDL effects — the one-month trial window was too short to detect benefit.
- Stronger supplements like berberine, bergamot, and psyllium were excluded; the trial was funded by Crestor's manufacturer.
Methodology
This is an evidence-review video by Dr. Michael Greger of NutritionFacts.org, a nonprofit nutrition research platform with high credibility in evidence-based dietary science. The video is the 13th in a deep-dive series on cholesterol lowering, drawing primarily from a single landmark RCT (the SPORT trial) while contextualizing it with supplementary literature. Greger applies critical appraisal skills to highlight funding bias and product quality issues.
Study Limitations
The video critiques one RCT and does not present a systematic review of all supplement evidence — viewers should consult primary meta-analyses for berberine, bergamot, and psyllium specifically. Greger's advocacy for plant-based dietary approaches may introduce editorial bias in how supplement and drug evidence is framed. Individual LDL response to both statins and dietary changes varies significantly and should be monitored with a clinician.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
